Markush search in Thomson Reuters' DWPI
Join ChemAxon's David Deng, Application Scientist and guest speaker Donald Walter, product specialist at Thomson Reuters, as they talk about what kind of tasks can be solved using ChemAxon's Markush technology in Thomson Reuters' DWPI database. Don's primary job is to train users on Thomson Reuters' databases and solutions, specializing in patent and chemical information, and he also works with the Thomson Reuters Search Service, conducting searches and analyses for legal and industrial clients, with a special emphasis on pharmaceutical and chemical subjects.
To provide the widest availability worldwide, we will repeat the webinar in two different sessions on two different days. The first session will start at 1.00 pm EST on the 27th of January for those who prefer the midday/mid afternoon hours on the East Coast and for Europe. The second session starts at 9.00 am EST on the 31st of January to let West Coast reach the session in a convenient time. Please read the title of the webinar and its short abstract below:
Chemical Structures Hidden in Patents; Markush Data in the Derwent World Patents Index with ChemAxon Software
Join us for a webinar on how to find patents containing specific and Markush chemical structures that you or your competitors may have patented. Patents sometime mentioned chemical structures explicitly (e.g. Amoxicillin) and sometimes only implicitly (e.g. “A compound having the formula I, where R1 = A, B, C, …, R2 = X, Y, Z, …,” etc.). The latter type of disclosure, called a Markush structure, may protect your compound without explicitly mentioning it. Furthermore, a Markush may cover an astronomical number of structures, only a few of which might lead to your application. We will demonstrate how you can find both specific chemical structures and Markush structures in patents, how to find those patents which disclose your structure for a given application and suggest convenient ways in which these structures can be explored in your research. This information can be used for research, patentability, freedom to operate, patent defense and other critical decisions. This presentation is open only to users and those considering the solution. We reserve the right to restrict attendance.
For more information on the event please contact Alex Allardyce via email.